ArticleAnnals of transplantation2021

Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors.

Ruoyang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.